Miami, United States, July 22nd, 2026, Chainwire
Unserious today announced the acquisition of Creepz, one of the most recognizable NFT collections of the 2021-22 cycle. Backed by entrepreneur and investor Adam Weitsman, and with the support of the original founders, the deal places the lizard cult brand under a powerhouse new team.
Most importantly, the acquisition marks a homecoming for Psychrome – the original mastermind and creative genius behind the Creepz lore. Returning to lead IP development, he also brings a resume as a globally exhibited artist whose commercial collaborations span Nike, Salomon, Sneaker Con, Staple, Disney, Warner Bros., and Rovio.
Beyond this foundational creative leadership, the Unserious team brings deep operating experience with a track record spanning consumer brands, entertainment, and enterprise tech, alongside crypto’s largest token launches – including the historic ApeCoin.
Unserious also took the opportunity to formally deny the existence of lizard people, their alleged evil activities, and any plans for $CREEPZ world domination.
About Unserious
Unserious is reimagining the future of decentralized brands.
Contact
Acquirer
Unserious
Unserious
[email protected]
Stay informed with daily updates from Blockchain Magazine on Google News. Click here to follow us and mark as favorite: [Blockchain Magazine on Google News].
Disclaimer: Any post shared by a third-party agency are sponsored and Blockchain Magazine has no views on any such posts. The views and opinions expressed in this post are those of the clients and do not necessarily reflect the official policy or position of Blockchain Magazine. The information provided in this post is for informational purposes only and should not be considered as financial, investment, or professional advice. Blockchain Magazine does not endorse or promote any specific products, services, or companies mentioned in this posts. Readers are encouraged to conduct their own research and consult with a qualified professional before making any financial decisions.